Neutrophil-lymphocyte ratio predicts survival in platinum-resistant ovarian cancer patients treated with olaparib and pegylated liposomal doxorubicin (PLD): Stratified analysis from the phase II clinical trial ROLANDO, GEICO-1601
No Thumbnail Available
Identifiers
Date
2021-09-21
Authors
Perez Fidalgo, J. A.
Cortes, A.
Garcia, Y.
Iglesias, M.
Bohn Sarmiento, U.
Calvo Garcia, E.
Manso, L.
Santaballa, A.
Oaknin, A.
Redondo, A.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
